8 results match your criteria: "Sakai Hospital Kindai University Faculty of Medicine[Affiliation]"
Oncologist
March 2019
Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
Intern Med
May 2018
Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan.
Patients with mycosis fungoides (MF), the most common subtype of primary cutaneous T-cell lymphoma, have an increased risk of developing secondary malignancies. We herein report two rare cases of MF concurring with diffuse large B cell lymphoma (B lymphoid lineage) and acute myeloid leukemia (myeloid lineage) in two otherwise healthy elderly patients. Potential etiologic factors, including the impact of the therapy-associated inflammatory response on the development of secondary tumors in patients with MF, are discussed.
View Article and Find Full Text PDFEur Neurol
April 2018
Department of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.
To our knowledge, this is the first study to report the time course of radiological imaging of 3 patients from 2 families with VCP-related amyotrophic lateral sclerosis (ALS) and dementia. Both families shared the same p.Arg487His mutation in the VCP gene encoding valosin-containing protein.
View Article and Find Full Text PDFJ Neurol Sci
July 2017
Department of Neurology, Kindai University Faculty of Medicine, Japan.
Introduction: Early onset ataxia with ocular motor apraxia and hypoalbuminemia (EAOH)/ataxia with oculomotor apraxia 1 (AOA1) is an autosomal recessive disorder caused by mutations in the APTX gene. In contrast to the recent progress on the molecular mechanism of aprataxin in DNA repair, the genotype and phenotype correlation has not been fully established. A previous study demonstrated that patients with truncation mutations had earlier onset of disease than those with missense mutations METHODS: Genomic DNA analysis was performed in a consanguineous family with relatively late-onset EAOH/AOA1.
View Article and Find Full Text PDFCase Rep Neurol
January 2017
Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Japan.
We report the first patient with pathologically proven leukoencephalopathy associated with hypophosphatemia. A 61-year-old woman had repetitive episodes of decreased consciousness with pontine and pallidal lesions and extensive leukoencephalopathy on MRI, later found to be associated with hypophosphatemia. Although hypophosphatemia has been linked to central pontine and extrapontine myelinolysis (osmotic myelinolysis), lesions in the deep white matter have not been reported.
View Article and Find Full Text PDFJ Neuroimmunol
December 2016
Department of Neurology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address:
Whether patients who have GBS with antibodies to galactocerebroside (Gal-C) and gangliosides (Gal-C-GS-GBS) more often have demyelinating or axonal neuropathy remains controversial. We assessed the electrophysiological data from 16 patients with Gal-C-GS-GBS based on the two established criteria to clarify this issue. In this largest cohort of Gal-C-GS-GBS, eight patients had demyelinating neuropathy and none exhibited axonal neuropathy on either criterion.
View Article and Find Full Text PDFJ Peripher Nerv Syst
December 2016
Department of Neurology, Sakai Hospital Kindai University Faculty of Medicine, Sakai, Japan.
Charcot-Marie-Tooth (CMT) disease is a complex of peripheral nervous system disorders. CMT type 2U (CMT2U) is an autosomal dominant (AD) disease caused by mutations in the MARS gene encoding methionyl-tRNA synthetase; this disease has thus been newly called AD-CMTax-MARS. A few families with mutations in the MARS gene have been reported, without detailed histopathological findings.
View Article and Find Full Text PDFIntern Med
March 2017
Department of Cardiology, Sakai Hospital Kindai University Faculty of Medicine, Japan.
Amyloidosis is a well-known but uncommon disease, and the physician must maintain a high index of suspicion in order to make a timely diagnosis. The expected survival of patients with cardiac amyloidosis is generally poor. In particular, survival has been reported to be 4-12 months for patients with amyloid light-chain amyloidosis with congestive heart failure.
View Article and Find Full Text PDF